Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
(2019) In Scientific Reports 9(1).- Abstract
Metastatic melanoma is one of the most common deadly cancers, and robust biomarkers are still needed, e.g. to predict survival and treatment efficiency. Here, protein expression analysis of one hundred eleven melanoma lymph node metastases using high resolution mass spectrometry is coupled with in-depth histopathology analysis, clinical data and genomics profiles. This broad view of protein expression allowed to identify novel candidate protein markers that improved prediction of survival in melanoma patients. Some of the prognostic proteins have not been reported in the context of melanoma before, and few of them exhibit unexpected relationship to survival, which likely reflects the limitations of current knowledge on melanoma and... (More)
Metastatic melanoma is one of the most common deadly cancers, and robust biomarkers are still needed, e.g. to predict survival and treatment efficiency. Here, protein expression analysis of one hundred eleven melanoma lymph node metastases using high resolution mass spectrometry is coupled with in-depth histopathology analysis, clinical data and genomics profiles. This broad view of protein expression allowed to identify novel candidate protein markers that improved prediction of survival in melanoma patients. Some of the prognostic proteins have not been reported in the context of melanoma before, and few of them exhibit unexpected relationship to survival, which likely reflects the limitations of current knowledge on melanoma and shows the potential of proteomics in clinical cancer research.
(Less)
- author
- organization
-
- Clinical Protein Science and Imaging (research group)
- Tumor microenvironment
- Melanoma Genomics (research group)
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- Clinical Chemistry, Malmö (research group)
- CEBMMS PI (research group)
- Medical oncology
- Department of Biomedical Engineering
- Stem Cell Metabolism (research group)
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy
- Lund Melanoma Study Group (research group)
- EpiHealth: Epidemiology for Health
- Breastcancer-genetics
- publishing date
- 2019-03-26
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Scientific Reports
- volume
- 9
- issue
- 1
- article number
- 5154
- publisher
- Nature Publishing Group
- external identifiers
-
- scopus:85063494011
- pmid:30914758
- ISSN
- 2045-2322
- DOI
- 10.1038/s41598-019-41625-z
- language
- English
- LU publication?
- yes
- id
- e2298e78-7a9c-4979-8670-07c0a2968b0c
- date added to LUP
- 2019-04-05 09:58:42
- date last changed
- 2024-10-01 19:42:34
@article{e2298e78-7a9c-4979-8670-07c0a2968b0c, abstract = {{<p>Metastatic melanoma is one of the most common deadly cancers, and robust biomarkers are still needed, e.g. to predict survival and treatment efficiency. Here, protein expression analysis of one hundred eleven melanoma lymph node metastases using high resolution mass spectrometry is coupled with in-depth histopathology analysis, clinical data and genomics profiles. This broad view of protein expression allowed to identify novel candidate protein markers that improved prediction of survival in melanoma patients. Some of the prognostic proteins have not been reported in the context of melanoma before, and few of them exhibit unexpected relationship to survival, which likely reflects the limitations of current knowledge on melanoma and shows the potential of proteomics in clinical cancer research.</p>}}, author = {{Betancourt, Lazaro Hiram and Pawłowski, Krzysztof and Eriksson, Jonatan and Szasz, A. Marcell and Mitra, Shamik and Pla, Indira and Welinder, Charlotte and Ekedahl, Henrik and Broberg, Per and Appelqvist, Roger and Yakovleva, Maria and Sugihara, Yutaka and Miharada, Kenichi and Ingvar, Christian and Lundgren, Lotta and Baldetorp, Bo and Olsson, Håkan and Rezeli, Melinda and Wieslander, Elisabet and Horvatovich, Peter and Malm, Johan and Jönsson, Göran and Marko-Varga, György}}, issn = {{2045-2322}}, language = {{eng}}, month = {{03}}, number = {{1}}, publisher = {{Nature Publishing Group}}, series = {{Scientific Reports}}, title = {{Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data}}, url = {{http://dx.doi.org/10.1038/s41598-019-41625-z}}, doi = {{10.1038/s41598-019-41625-z}}, volume = {{9}}, year = {{2019}}, }